RECENT NEWS

Childhood exposure to a toxin produced by E. coli could be contributing to the rise of bowel cancer in under-50s, according to research funded by Cancer Research UK.

A 12-month roll-out has commenced to deliver the most significant update to UK clinical trials regulation in two decades – with the aim of strengthening patient safety, accelerating approvals, enabling innovation and helping more people benefit from taking part in vital research.

​Scientists from Northwestern University, in the US, have identified that piperacillin, an antibiotic in the same class as penicillin, effectively cured mice of Lyme disease at 100-times less than the effective dose of doxycycline, the current gold standard treatment.

A new strategy for tuberculosis (TB) screening, proposed by a team of researchers led by Queen Mary University of London, could provide a solution to problems with current TB screening, which does not always accurately detect disease.

Fatigue among NHS healthcare staff poses a significant yet under-recognised risk to patient safety, according to HSSIB’s latest investigation report.

The Association of Surgeons of Great Britain and Ireland (ASGBI) has announced its collaboration with the Royal College of Surgeons of Edinburgh (RCSEd) and Surgeons Quarter for the ASGBI International Surgical Congress.

The Association for Perioperative Practice (AfPP) has announced the appointment of Jody Carvell as the new Trent Regional Lead.

Eleven cutting-edge robotic surgery systems have been approved for use, potentially transforming care for thousands of NHS patients undergoing soft tissue and orthopaedic procedures.

A new, independent survey of 2,000 UK adults, by nuom, has revealed growing concern among people with disabilities that the rise of AI in healthcare could lead to exclusion for those less confident with technology.

APIS Assay Technologies, a private UK based company specialising in molecular diagnostics, has announced the extension of the highly successful DEVOTE grant award from the UK Government’s Innovation Accelerator programme led by Innovate UK.

A nurse providing specialist rehabilitative care to patients with life-changing spinal injuries at one of the UK’s leading spinal injury units has won a top national award.

COMPASS (Culture of Organisations and its iMpact on PAtientS’ Safety) is a new patient safety tool to help understand the impact of organisational culture on patient safety and is currently being trialled across 12 Trusts.

New findings from a national survey of bank only workers in the NHS reveal a concerning rise in incidents of physical violence and discrimination from patients and the public over the past year.

The Royal College of Physicians (RCP) has responded to the latest NHS England performance data, saying that tackling both the outdated model of outpatient care and the social determinants of health are key to bringing down waiting lists.

People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful valve surgery. This is according to a new study from Karolinska Institutet and Karolinska University Hospital in Sweden published in the European Heart Journal. The condition is more common in women and younger patients with valve disorder and can, in the worst case, lead to sudden cardiac arrest.

The Royal College of Obstetricians and Gynaecologists (RCOG) has partnered with Maternity Action to publish joint guidance for obstetricians in England on NHS maternity care charging.

The NHS waiting list for routine hospital treatment in England has fallen for the sixth consecutive month, with 7.4 million patient pathways recorded at the end of February 2025, down 26,161 from January 2025. However, the Royal College of Surgeons (RCS) has warned that the state of hospitals is hampering efforts to tackle waiting lists.

A major study presented at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) face a 2.7-fold higher risk of death within one year compared to the general population.

A pioneering study presented at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient groups, including neonates, children and pregnant women.

Environmental factors, such changing temperatures and rainfall, are the main drivers associated with the spread of Oropouche virus (OROV) in Latin America, according to a modelling study published in The Lancet Infectious Diseases journal and presented at the ESCMID conference.